Could One Pill Target BOTH Parkinson's AND Alzheimer's? | Buntanetap Explained

Could a single pill slow down Parkinson's disease AND protect against Alzheimer's at the same time? That's the question researchers are asking about a drug called buntanetap — and the Phase 3 trial data is unlike anything we've covered on this channel before. In this video, I break down what buntanetap is, how it works, what the clinical trials have actually shown — including a surprising discovery about Parkinson's patients who also carry Alzheimer's-related proteins in their blood — and where the research stands right now in 2026. Could One Pill Target BOTH Parkinson's AND Alzheimer's? | Buntanetap Explained This is not an approved drug. This is educational content based on published research and clinical trial data. I am not a doctor. Always talk to your neurologist about your care. ⏱️ TIMESTAMPS: 0:00 - Could one pill treat both diseases? 0:47 - Introduction 1:22 - What is buntanetap? 2:51 - How does it work? (The mechanism explained) 4:14 - The Phase 3 Parkinson's trial & what it showed 7:30 - The Alzheimer's connection (the surprising finding) 8:11 - Why this matters for the Parkinson's community 9:23 - Where things stand right now (2026 update) 10:37 - Wrap-up 🔬 TREATMENTS & TRIALS COVERED: Buntanetap (also known as posiphen / ANVS401) — Annovis Bio Phase 3 Parkinson's trial (NCT05357989) — 471 patients, early PD Open-Label Extension study — 500 patients, launched January 2026 Phase 3 Alzheimer's trial — 760 patients, ongoing across 84 U.S. sites FDA meeting — January 2026 recommendation for Parkinson's disease dementia study You may enjoy these other videos: • The Virus in the Brain that they found in Parkinson's Patients:    • Half of Parkinson's patients have this vir...   • The Most Advanced Treatments in Clinical Trials right now:    • The Most Advanced Parkinson's Disease Trea...   • Exercise Slows Parkinson's Progression:    • Exercise Slows Parkinson's Progression | N...   • Parkinson's Vaccine Clinical Trial Update:    • The Parkinson's Vaccine Just Released Phas...   📚 KEY SOURCES & FURTHER READING: Buntanetap Phase 2 (Alzheimer's & Parkinson's): Fang C, et al. "Buntanetap, a Novel Translational Inhibitor of Multiple Neurotoxic Proteins, Proves to Be Safe and Promising in Both Alzheimer's and Parkinson's Patients." Journal of Prevention of Alzheimer's Disease (2023). PMID: 36641607 Buntanetap Phase 2/3 (Alzheimer's, peer-reviewed): Fang C, Feng D, Gaines M, et al. "Buntanetap treatment in mild to moderate Alzheimer's disease: phase 2/3 study." npj Dementia, Volume 2, Article 26 (2026). https://doi.org/10.1038/s44400-026-00... Phase 3 Parkinson's trial information: ClinicalTrials.gov: NCT05357989 Annovis Bio: https://www.annovisbio.com/parkinsons... Open-Label Extension & FDA update: ALZFORUM Therapeutics: https://www.alzforum.org/therapeutics... NeurologyLive (January 2025): https://www.neurologylive.com/view/fd... Safety monitoring update (February 2026): Psychiatric Times: https://www.psychiatrictimes.com/view... ❓ QUESTIONS FOR YOU: Had you heard of Buntanetap before this video? Does the Alzheimer's connection surprise you? Drop your thoughts in the comments — I read every one. 📺 RELATED VIDEOS: DBS vs. Focused Ultrasound — Which Is Right?:   • Focused Ultrasound Just Got Approved for M...   Can We Stop Parkinsons from Spreading :    • Can We Stop Parkinson's from Spreading? Wi...   High Dose Vitamin B1 — The Results Are In:    • Can High-Dose Thiamine Stop Parkinson's? W...   MDS UPDRS Rating Scale:    • Decode Your MDS-UPDRS Score Before Your Ne...   Parkinson's Vaccine Update -    • The Parkinson's Vaccine Just Released Phas...   🔔 SUBSCRIBE for weekly Parkinson's research updates. Research is moving fast — and you deserve to understand what it all means. ⚠️ DISCLAIMER: I am not a doctor or medical professional. I am a caregiver and daughter who spent over a decade walking the Parkinson's journey with my mom. This channel is educational content based on published research and clinical trial data. Always consult your neurologist before making any treatment decisions. ☕ Support this channel: https://buymeacoffee.com/heykimmi #ParkinsonsDisease #Buntanetap #AlzheimersDisease #ParkinsonsResearch #ClinicalTrials #DiseaseModifyingTherapy #NeurodegenerativeDisease #BrainHealth #ParkinsonsCaregiver #AlphasynucleinParkinsons #CognitiveDecline #ParkinsonsUpdate2026 #AnnovisBio #ParkinsonsAwareness #Dementia